“levodopa” Archives

in
Entry Author Date Location
Supernus Makes a Parkinson’s Play With $300M Deal for US WorldMeds Drugs 04/29/20 National
Acorda Cuts Staff 25% and Restructures to Keep Focus on Parkinson’s Drug 10/24/19 New York
Sunovion’s FDA Rejection Gives Acorda Parkinson’s Drug Breathing Room 01/31/19 Boston
Acorda Gets FDA Nod for New Parkinson’s Drug, But Rival Looms 12/24/18 New York
Impel Raises $67.5M to Advance Intranasal Drugs for CNS Disorders 12/06/18 Seattle
Acorda’s Tough Week Continues as FDA Delays Parkinson’s Drug Review 09/13/18 New York
With Acorda Data, Experts Weigh the Benefits of New Parkinson’s Drugs 04/25/18 New York
Sunovion Parkinson’s Drug Heads to FDA, Setting Up Battle With Acorda 01/30/18 Boston
Sanofi Pulls Back from Voyager Gene Therapy Pact in Parkinson’s 10/31/17 Boston
FDA Refuses to Review Acorda Parkinson’s Drug, Shares Tumble 08/29/17 New York
For Parkinson’s, Two New Drugs Coming As Prevail Gets Started in NY 08/09/17 New York
Acorda Touts Success in Parkinson’s Drug Study, Awaits Safety Data 02/09/17 New York
Voyager’s Gene Therapy for Parkinson’s Shows Promise in Small Study 12/07/16 Boston
Acorda Doubles Down on Parkinson, Buys Biotie For $363M 01/19/16 New York
WaVe, Voyager Get $170M Combined in Biotech’s Latest IPO Tests 11/11/15 Boston
East Coast Biotech Roundup: GliaCure, Civitas, T2, & More 09/29/14 Boston
Alkermes Spinoff Civitas, Poised for IPO, Sells to Acorda for $525M 09/24/14 Boston
East Coast Biotech Roundup: Concert, Merrimack, Vertex, & More 05/02/14 Boston
Third Rock’s Voyager Hunts For CNS Disorders With Gene Therapy 02/12/14 Boston
East Coast Life Sciences Roundup: Genocea, Biogen, OvaScience, & More 09/13/13 Boston
Civitas Scores $38M Series B For Parkinson’s Drug Push 09/11/13 Boston
Startups Progress with Novel Drugs for Parkinson’s Disease 10/29/12 New York
Page 1 of 1